Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Inc. buy mixitrader

Start price
€28.68
18.07.26 / 50%
Target price
€30.00
18.07.27
Performance (%)
1.88%
Price
€29.22
13:39
Summary
This prediction is currently active. With a performance of 1.88%, the BUY prediction by mixitrader for Hims & Hers Health Inc. is trending in the right direction. This prediction currently runs until 18.07.27. The prediction end date can be changed by mixitrader at any time. mixitrader has 50% into this prediction
Performance without dividends (%)
Name 1w
Hims & Hers Health Inc. 1.88%
iShares Core DAX® -0.464%
iShares Nasdaq 100 -1.413%
iShares Nikkei 225® -1.246%
iShares S&P 500 -1.147%

According to mixitrader what are the pros and cons of Hims & Hers Health Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bad rating
Few uniques
Lower EBIT Margin than peer group
High valuation
Little innovation
Business model of the past or high risk
Low dividend yield expected
Sustainability is little important
Higher risks for its business
Below average Marketposition
negative Cash Flow expected
Little Investments for future growth
Below average Management
Bad culture
Dependend from some customers or products
Significant cyclical dependencies
Little known brand
Risky balance sheet
Growths slower than the competition
high free float
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by mixitrader for this prediction

In the thread Hims & Hers Health Inc. diskutieren
Prediction Buy
Perf. (%) 1.88%
Target price 30.000
Change
Ends at

Buy mit Kursziel 30,0

Stopped prediction by mixitrader for Hims & Hers Health Inc.

Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€21.87
14.03.26
€10.00
14.03.27
-23.14%
28.03.26

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bad rating